|
Public Act 096-1078 |
SB2931 Enrolled | LRB096 17757 KTG 35199 b |
|
|
AN ACT concerning public aid.
|
Be it enacted by the People of the State of Illinois,
|
represented in the General Assembly:
|
Section 1. Short title. This Act may be cited as the |
Pediatric Palliative Care Act. |
Section 5. Legislative findings. The General Assembly |
finds as follows: |
(1) Each year, approximately 1,185 Illinois children |
are diagnosed with a potentially life-limiting illness. |
(2) There are many barriers to the provision of |
pediatric palliative services, the most significant of |
which include the following: (i) challenges in predicting |
life expectancy; (ii) the reluctance of families and |
professionals to acknowledge a child's incurable |
condition; and (iii) the lack of an appropriate, |
pediatric-focused reimbursement structure leading to |
insufficient community-based resources. |
(3) It is tremendously difficult for physicians to |
prognosticate pediatric life expectancy due to the |
resiliency of children. In addition, parents are rarely |
prepared to cease curative efforts in order to receive |
hospice or palliative care. Community-based pediatric |
palliative services, however, keep children out of the |
|
hospital by managing many symptoms in the home setting, |
thereby improving childhood quality of life while |
maintaining budget neutrality.
|
(4) Pediatric palliative programming can, and should, |
be administered in a cost neutral fashion. Community-based |
pediatric palliative care allows for children and families |
to receive pain and symptom management and psychosocial |
support in the comfort of the home setting, thereby |
avoiding excess spending for emergency room visits and |
certain hospitals. The National Hospice and Palliative |
Care Organization's pediatric task force reported during |
2001 that the average cost per child per year, cared for |
primarily at home, receiving comprehensive palliative and |
life prolonging services concurrently, is $16,177, |
significantly less than the $19,000 to $48,000 per child |
per year when palliative programs are not utilized. |
Section 10. Definition. In this Act, "Department" means the |
Department of Healthcare and Family Services. |
Section 15. Pediatric palliative care pilot program. The |
Department shall develop a pediatric palliative care pilot |
program under which a qualifying child as defined in Section 25 |
may receive community-based pediatric palliative care from a |
trained interdisciplinary team while continuing to pursue |
aggressive curative treatments for a potentially life-limiting |
|
illness under the benefits available under Article V of the |
Illinois Public Aid Code. |
Section 20. Federal waiver or State Plan amendment. The |
Department shall submit the necessary application to the |
federal Centers for Medicare and Medicaid Services for a waiver |
or State Plan amendment to implement the pilot program |
described in this Act. If the application is in the form of a |
State Plan amendment, the State Plan amendment shall be filed |
prior to December 31, 2010. If the Department does not submit a |
State Plan amendment prior to December 31, 2010, the pilot |
program shall be created utilizing a waiver authority. The |
waiver request shall be included in any appropriate waiver |
application renewal submitted prior to December 31, 2011, or |
shall be submitted as an independent 1915(c) Home and Community |
Based Medicaid Waiver within that same time period. After |
federal approval is secured, the Department shall implement the |
waiver or State Plan amendment within 12 months of the date of |
approval. By federal requirement, the application for a 1915 |
(c) Medicaid waiver program must demonstrate cost neutrality |
per the formula laid out by the Centers for Medicare and |
Medicaid Services. The Department shall not draft any rules in |
contravention of this timetable for pilot program development |
and implementation. This pilot program shall be implemented |
only to the extent that federal financial participation is |
available. |
|
Section 25. Qualifying child. |
(a) For the purposes of this Act, a qualifying child is a |
person under 18 years of age who is enrolled in the medical |
assistance program under Article V of the Illinois Public Aid |
Code and suffers from a potentially life-limiting medical |
condition, as defined in subsection (b). A child who is |
enrolled in the pilot program prior to the age 18 may continue |
to receive services under the pilot program until the day |
before his or her twenty-first birthday.
|
(b) The Department, in consultation with interested |
stakeholders, shall determine the potentially life-limiting |
medical conditions that render a pediatric medical assistance |
recipient eligible for the pilot program under this Act. Such |
medical conditions shall include, but need not be limited to, |
the following: |
(1) Cancer (i) for which there is no known effective |
treatment, (ii) that does not respond to conventional |
protocol, (iii) that has progressed to an advanced stage, |
or (iv) where toxicities or other complications prohibit |
the administration of curative therapies. |
(2) End-stage lung disease, including but not limited |
to cystic fibrosis, that results in dependence on |
technology, such as mechanical ventilation. |
(3) Severe neurological conditions, including, but not |
limited to, hypoxic ischemic encephalopathy, acute brain |
|
injury, brain infections and inflammatory diseases, or |
irreversible severe alteration of mental status, with one |
of the following co-morbidities: (i) intractable seizures |
or (ii) brainstem failure to control breathing or other |
automatic physiologic functions. |
(4) Degenerative neuromuscular conditions, including, |
but not limited to, spinal muscular atrophy, Type I or II, |
or Duchenne Muscular Dystrophy, requiring technological |
support. |
(5) Genetic syndromes, such as Trisomy 13 or 18, where |
(i) it is more likely than not that the child will not live |
past 2 years of age or (ii) the child is severely |
compromised with no expectation of long-term survival. |
(6) Congenital or acquired end-stage heart disease, |
including but not limited to the following: (i) single |
ventricle disorders, including hypoplastic left heart |
syndrome; (ii) total anomalous pulmonary venous return, |
not suitable for curative surgical treatment; and (iii) |
heart muscle disorders (cardiomyopathies) without adequate |
medical or surgical treatments. |
(7) End-stage liver disease where (i) transplant is not |
a viable option or (ii) transplant rejection or failure has |
occurred. |
(8) End-stage kidney failure where (i) transplant is |
not a viable option or (ii) transplant rejection or failure |
has occurred. |
|
(9) Metabolic or biochemical disorders, including, but |
not limited to, mitochondrial disease, leukodystrophies, |
Tay-Sachs disease, or Lesch-Nyhan syndrome where (i) no |
suitable therapies exist or (ii) available treatments, |
including stem cell ("bone marrow") transplant, have |
failed. |
(10) Congenital or acquired diseases of the |
gastrointestinal system, such as "short bowel syndrome", |
where (i) transplant is not a viable option or (ii) |
transplant rejection or failure has occurred. |
(11) Congenital skin disorders, including but not |
limited to epidermolysis bullosa, where no suitable |
treatment exists.
|
The definition of a life-limiting medical condition shall |
not include a definitive time period due to the difficulty and |
challenges of prognosticating life expectancy in children. |
Section 30. Authorized providers. Providers authorized to |
deliver services under the pilot waiver program shall include |
licensed hospice agencies or home health agencies licensed to |
provide hospice care and will be subject to further criteria |
developed by the Department for provider participation. At a |
minimum, the participating provider must house a pediatric |
interdisciplinary team that includes a pediatric medical |
director, a nurse, and a licensed social worker. All members of |
the pediatric interdisciplinary team must submit to the |
|
Department proof of pediatric End-of-Life Nursing Education |
Curriculum (Pediatric ELNEC Training) or an equivalent. |
Section 35. Interdisciplinary team; services. Subject to |
federal approval for matching funds, the reimbursable services |
offered under the pilot program shall be provided by an |
interdisciplinary team, operating under the direction of a |
pediatric medical director, and shall include, but not be |
limited to, the following: |
(1) Pediatric nursing for pain and symptom management. |
(2) Expressive therapies (music and art therapies) for |
age-appropriate counseling. |
(3) Client and family counseling (provided by a |
licensed social worker or non-denominational chaplain or |
spiritual counselor). |
(4) Respite care. |
(5) Bereavement services. |
(6) Case management. |
Section 40. Administration. |
(a) The Department shall oversee the administration of the |
pilot program. The Department, in consultation with interested |
stakeholders, shall determine the appropriate process for |
review of referrals and enrollment of qualifying participants. |
(b) The Department shall appoint an individual or entity to |
serve as case manager or an alternative position to assess |
|
level-of-care and target-population criteria for the pilot |
program. The Department shall ensure that the individual |
receives pediatric End-of-Life Nursing Education Curriculum |
(Pediatric ELNEC Training) or an equivalent to become |
familiarized with the unique needs and difficulties facing this |
population. The process for review of referrals and enrollment |
of qualifying participants shall not include unnecessary |
delays and shall reflect the fact that treatment of pain and |
other distressing symptoms represents an urgent need for |
children with life-limiting medical conditions. The process |
shall also acknowledge that children with life-limiting |
medical conditions and their families require holistic and |
seamless care.
|
Section 45. Period of pilot program. |
(a) The program implemented under this Act shall be |
considered a pilot program for 3 years following the date of |
program implementation or, if the pilot program is created |
utilizing a waiver authority, until the waiver that includes |
the services provided under the program undergoes the federally |
mandated renewal process. |
(b) During the period of time that the waiver program is |
considered a pilot program, pediatric palliative care shall be |
included in the issues reviewed by the Hospice and Palliative |
Care Advisory Board. The Board shall make recommendations |
regarding changes or improvements to the program, including but |
|
not limited to advisement on potential expansion of the |
potentially life-limiting medical conditions as defined in |
subsection (b) of Section 25. |
(c) At the end of the 3-year pilot program, the Department |
shall prepare a report for the General Assembly concerning the |
program's outcomes effectiveness and shall also make |
recommendations for program improvement, including, but not |
limited to, the appropriateness of the potentially |
life-limiting medical conditions as defined in subsection (b) |
of Section 25. |
Section 50. Effect on medical assistance program. |
(a) Nothing in this Act shall be construed so as to result |
in the elimination or reduction of any benefits or services |
covered under the medical assistance program under Article V of |
the Illinois Public Aid Code. |
(b) This Act does not affect an individual's eligibility to |
receive, concurrently with the benefits provided for in this |
Act, any services, including home health services, for which |
the individual would have been eligible in the absence of this |
Act.
|
Section 90. The Hospice Program Licensing Act is amended by |
changing Section 15 as follows: |
(210 ILCS 60/15) |
|
Sec. 15. Hospice and Palliative Care Advisory Board. |
(a) The Director shall appoint a Hospice and Palliative |
Care Advisory Board ("the Board") to consult with the |
Department as provided in this Section. The membership of the |
Board shall be as follows: |
(1) The Director, ex officio, who shall be a nonvoting |
member and shall serve as chairman of the Board. |
(2) One representative of each of the following State |
agencies, each of whom shall be a nonvoting member: the |
Department of
Healthcare and Family Services, the |
Department of Human Services, and the Department on Aging. |
(3) One member who is a physician licensed to
practice |
medicine in all its branches, selected from the |
recommendations of a statewide professional society |
representing physicians licensed to practice medicine in |
all its branches in all specialties. |
(4) One member who is a registered nurse,
selected from |
the recommendations of professional nursing associations. |
(5) Four members selected from the
recommendations of |
organizations whose primary membership consists of hospice |
programs. |
(6) Two members who represent the general
public and |
who have no responsibility for management or formation of |
policy of a hospice program and no financial interest in a |
hospice program. |
(7) One member selected from the
recommendations of |
|
consumer organizations that engage in advocacy or legal |
representation on behalf of hospice patients and their |
immediate families. |
(b) Of the initial appointees, 4 shall serve for terms of 2 |
years, 4 shall serve for terms of 3 years, and 5 shall serve |
for terms of 4 years, as determined by lot at the first meeting |
of the Board. Each successor member shall be appointed for a |
term of 4 years. A member appointed to fill a vacancy before |
the expiration of the term for which his or her predecessor was |
appointed shall be appointed to serve for the remainder of that |
term. |
(c) The Board shall meet as frequently as the chairman |
deems necessary, but not less than 4 times each year. Upon the |
request of 4 or more Board members, the chairman shall call a |
meeting of the Board. A Board member may designate a |
replacement to serve at a Board meeting in place of the member |
by submitting a letter stating that designation to the chairman |
before or at the Board meeting. The replacement member must |
represent the same general interests as the member being |
replaced, as described in paragraphs (1) through (7) of |
subsection (a). |
(d) Board members are entitled to reimbursement for their |
actual expenses incurred in performing their duties. |
(e) The Board shall advise the Department on all aspects of |
the Department's responsibilities under this Act, including |
the format and content of any rules adopted by the Department |
|
on or after the effective date of this amendatory Act of the |
95th General Assembly. Any such rule or amendment to a rule |
proposed on or after the effective date of this amendatory Act |
of the 95th General Assembly, except an emergency rule adopted |
pursuant to Section 5-45 of the Illinois Administrative |
Procedure Act, that is adopted without obtaining the advice of |
the Board is null and void. If the Department fails to follow |
the advice of the Board with respect to a proposed rule or |
amendment to a rule, the Department shall, before adopting the |
rule or amendment to a rule, transmit a written explanation of |
the reason for its action to the Board. During its review of |
rules, the Board shall analyze the economic and regulatory |
impact of those rules. If the Board, having been asked for its |
advice with respect to a proposed rule or amendment to a rule, |
fails to advise the Department within 90 days, the proposed |
rule or amendment shall be considered to have been acted upon |
by the Board.
|
(f) The Board shall also review pediatric palliative care |
issues as provided in the Pediatric Palliative Care Act. |
(Source: P.A. 95-133, eff. 1-1-08.)
|
Section 99. Effective date. This Act takes effect upon |
becoming law.
|